New Treatment for Endometriosis Approved

A new daily pill, Wohl norithisterone or RIECO, has been approved by the NHS to treat endometriosis, a condition affecting about 1.5 million women in the UK. This treatment aims to alleviate chronic pain and fatigue associated with the illness, which is characterized by the growth of tissue similar to the womb lining outside the uterus. Unlike existing injectable treatments, RIECO is designed to manage symptoms more effectively while allowing patients to administer it at home, reducing the need for frequent clinic visits. The approval, praised by Endometriosis UK, comes after evidence presented by the manufacturer indicated the drug's effectiveness, reversing an earlier rejection by NICE.